|
2006P-0503:
ANDA Suitability for Propoxyphene Napsylate and Acetaminophen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 12/07/2006
|
| 12/07/2006
|
| Private Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
|
|
| ACK1
|
| 12/07/2006
|
| 12/07/2006
|
| Federal Government
|
| FDA / DDM to Lachman
Consultant Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
|
|
Top
| Up
Page last updated:
January 16, 2007
|
